SkinnyRx vs Enhance MD: Oral semaglutide, pricing, and access compared
When comparing SkinnyRx vs Enhance MD, the quick verdict is: SkinnyRx focuses on daily oral semaglutide tablets with FSA/HSA eligibility and free overnight shipping, while Enhance MD emphasizes very low first-month pricing and flat-rate pricing plus access to both semaglutide and tirzepatide. This article directly compares the two across the strongest supported differences so you can decide which model fits your needs.
Explore SkinnyRx oral semaglutide
Key differences at a glance for SkinnyRx vs Enhance MD
This comparison highlights five distinctive, supported differences: price and introductory offers, formulation and compound options, pricing model and predictability, payment and account flexibility, and shipping and scale. Each section contrasts the two providers using only the supplied facts and qualifiers.
1. Price and introductory offers
Enhance MD advertises semaglutide from $49 for the first month and tirzepatide from $99 for the first month, described as the cheapest first-month pricing for either compound. SkinnyRx lists oral semaglutide tablets as low as $249/mo. Enhance MD emphasizes a low entry price to begin treatment; SkinnyRx positions a recurring monthly price starting at $249.
See Enhance MD first-month pricing
2. Formulation and compound availability
SkinnyRx offers daily oral semaglutide tablets designed with clinically supported ingredients and presented as an oral alternative to GLP-1 injections. Enhance MD provides access to both compounded semaglutide and compounded tirzepatide on one platform, with semaglutide first-month pricing from $49 and tirzepatide from $99. If having a tablet option is decisive, SkinnyRx highlights oral tablets specifically; if access to tirzepatide as well as semaglutide matters, Enhance MD documents both compounds.
3. Pricing model and predictability
Enhance MD promotes flat-rate pricing: the same price at every dose with no fee escalation during titration, and it notes ongoing flat-rate costs after the introductory period. SkinnyRx advertises a monthly price point described as as low as $249/mo and mentions options to split payments with Affirm Buy Now Pay Later. Enhance MD is positioned for people who want predictable same-price-at-every-dose billing; SkinnyRx emphasizes an as low as monthly rate with payment-split options.
4. Payment flexibility and accounts
SkinnyRx states FSA/HSA eligible, letting customers use pre-tax dollars toward treatment, and notes free overnight shipping. Enhance MD operates on a direct-pay model and does not bill insurance; it highlights very low first-month pricing and flat-rate ongoing costs. The FSA/HSA eligibility claim is presented only for SkinnyRx in the supplied facts; Enhance MD’s materials specify direct-pay and do not indicate insurance billing.
Check SkinnyRx FSA/HSA eligibility
5. Shipping, scale, and testing
SkinnyRx includes free overnight shipping on all orders and cites trust by 50,000+ weight loss patients, plus partner pharmacies perform third-party testing every 3 to 6 months to confirm compounded lot concentration within plus or minus 10 percent. Enhance MD reports treating 10,000+ patients and highlights clinical volume; both providers note that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. SkinnyRx specifically calls out free overnight shipping and its testing cadence.
| Criteria | SkinnyRx | Enhance MD |
|---|---|---|
| Starting price | As low as $249/mo | Semaglutide from $49 first month; tirzepatide from $99 first month |
| Formulation | Daily oral semaglutide tablets | Compounded semaglutide and tirzepatide available |
| Pricing model | Monthly pricing, Affirm Buy Now Pay Later available | Flat-rate pricing: same price at every dose after intro |
| Payment options | FSA/HSA eligible; use pre-tax dollars | Direct-pay; does not bill insurance |
| Shipping | Free overnight shipping on all orders | Not specified in supplied facts |
| Clinical volume | Trusted by 50,000+ weight loss patients | 10,000+ patients treated |
| Regulatory note | Compounded medications are not FDA-approved; partner pharmacies test lots every 3 to 6 months | Compounded medications are not FDA-approved; clinician-directed compounds |
Practical considerations and clinician review
Both platforms require clinician review before treatment. SkinnyRx notes prescriptions are available only if prescribed after an online consultation and that medication is processed after prescription review. Enhance MD describes clinician-directed compounds and treatment available when a licensed clinician determines it is medically appropriate. Both sources include the regulatory qualifier that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality.
Compare Enhance MD compound options
Conclusion: Choosing between SkinnyRx vs Enhance MD
Use the primary keyword SkinnyRx vs Enhance MD to recall the core trade-offs: choose SkinnyRx if you prioritize daily oral semaglutide tablets, FSA/HSA eligibility, free overnight shipping, and partner-pharmacy testing cadence. Choose Enhance MD if you want the lowest first-month pricing for semaglutide or tirzepatide and a flat-rate, same-price-at-every-dose model that avoids escalation during titration. Both require clinician review and both offer compounded medication options with the regulatory limitations supplied.